A Phase I/II Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Conditions:   Adenocarcinoma;   Pancreatic Neoplasms;   Neoplasm, Glandular;   Neoplasms;   Neoplasms Pancreatic;   Digestive System Neoplasm;   Endocrine Gland Neoplasms;   Digestive System Disease;   Pancreatic Diseases;   Endocrine System Diseases Interventions:   Drug: Nab-paclitaxel;   Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Cisplatin;   Drug: Irinotecan Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials